Charlie Newman
Corporate Officer/Principal at AGIOS PHARMACEUTICALS, INC.
Network origin in Charlie Newman first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 28 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Charlie Newman via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Medical Specialties | Corporate Officer/Principal | |
| CELGENE | Biotechnology | Director of Finance/CFO Comptroller/Controller/Auditor | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Human Resources Officer Human Resources Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PEPSICO, INC. | Food: Specialty/Candy | Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Operating Officer Corporate Officer/Principal | |
| EXACT SCIENCES CORPORATION | Medical Specialties | Director/Board Member | |
Bunge Ltd.
 Bunge Ltd. Agricultural Commodities/MillingProcess Industries Bunge Global SA operates as a holding company. engages in the supply and transportation of agricultural commodities. It operates through the following segments: Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy. The Agribusiness segment is involved in the purchase, storage, transportation, processing, and sale of agricultural commodities and commodity products. The Refined and Specialty Oils segment engages in the processing, production, and marketing of products derived from vegetable oils. The Milling segment consists of the processing, production, and marketing of products derived primarily from wheat and corn. The Sugar and Bioenergy segment includes the manufacture and marketing of sugar and ethanol derived from sugarcane, as well as energy derived from the sugar and ethanol production process. The company was founded by Johann Peter Gottlieb Bunge in 1818 and is headquartered in St. Louis, MO. | Agricultural Commodities/Milling | Director of Finance/CFO Comptroller/Controller/Auditor | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | President | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Stromedix, Inc.
 Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Stromedix, Inc. develops novel drugs to treat fibrosis and fibrotic organ failure. The company was founded by Michael Gilman in 2006 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| DICERNA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ZS PHARMA INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Neurovance, Inc.
 Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Neurovance, Inc. operates as a a biopharmaceutical company. It develops treatments for central nervous system disorders. The company was founded by Anthony McKinney and Franklin P. Bymaster in 2011 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chief Operating Officer | |
| BAXALTA INC | Biotechnology | Corporate Officer/Principal | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| AFFYMAX, INC. | Biotechnology | Corporate Officer/Principal | |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Founder | |
| BLUEBIRD BIO, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Babson College | College/University | Undergraduate Degree Undergraduate Degree | |
| The Johns Hopkins University | College/University | Graduate Degree | |
| Skidmore College | College/University | Undergraduate Degree | |
| The University of North Carolina at Chapel Hill | College/University | Undergraduate Degree | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| French-American Foundation | Director/Board Member | ||
GV Management Co. LLC
 GV Management Co. LLC Investment ManagersFinance GV Management Co LLC (Google Ventures) is a venture capital firm, a subsidiary of Google LLC founded in 2009 by Bill Maris. The firm is headquartered in Mountain View, California with an additional office in San Francisco, Boston, New York and London. | Investment Managers | Private Equity Investor Consultant / Advisor | |
| Harvard Medical School | College/University | Director/Board Member Graduate Degree | |
| Pathways to College Network | Director/Board Member | ||
| SPERO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
| Georgetown University School of Medicine | College/University | Doctorate Degree | |
| Eagleton Institute of Politics | College/University | Graduate Degree | |
GRAIL LLC
 GRAIL LLC Electronic Equipment/InstrumentsElectronic Technology GRAIL LLC is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
| XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
| PROTARA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| PRIME MEDICINE, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Transcend Therapeutics
 Transcend Therapeutics BiotechnologyHealth Technology Transcend Therapeutics is an American biotechnology company that discovers, develops, and delivers next-generation psychoactive medicines to work towards a world where people no longer suffer from neuropsychiatric disease. The company is located in the US. The company focuses on developing medicines that are accessible to a larger percentage of patients in need, specifically the tens of millions of patients who already take psychotropic medication. Transcend Therapeutics has real-world data for its lead compound, TSND-201, demonstrating robust responses in patients with PTSD. As a public benefit corporation, the company has pledged 10% of its founding shares towards nonprofits focused on scientific research and patient access. | Biotechnology | Director/Board Member Director/Board Member |
Statistics
International
| United States | 50 |
| Japan | 2 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 12 |
| Finance | 4 |
| Commercial Services | 3 |
| Consumer Non-Durables | 2 |
Operational
| Director/Board Member | 135 |
| Corporate Officer/Principal | 61 |
| Independent Dir/Board Member | 51 |
| Undergraduate Degree | 21 |
| Chairman | 18 |
Most connected contacts
| Insiders | |
|---|---|
| John Maraganore | 38 |
| Ian Clark | 35 |
| David Scadden | 26 |
| David Schenkein | 18 |
| Jacqualyn Fouse | 18 |
| Jonathan Biller | 17 |
| May Kin Ho | 16 |
| Kaye Foster-Cheek | 16 |
| Jeffrey Capello | 14 |
| Paul Clancy | 14 |
| Cynthia Smith | 13 |
| Rahul Ballal | 13 |
| Catherine Owen | 10 |
| Brian Goff | 10 |
| Melissa McLaughlin | 10 |
- Stock Market
- Insiders
- Charlie Newman
- Company connections
